222 related articles for article (PubMed ID: 21712447)
1. Novel functional germline variants in the VEGF receptor 2 gene and their effect on gene expression and microvessel density in lung cancer.
Glubb DM; Cerri E; Giese A; Zhang W; Mirza O; Thompson EE; Chen P; Das S; Jassem J; Rzyman W; Lingen MW; Salgia R; Hirsch FR; Dziadziuszko R; Ballmer-Hofer K; Innocenti F
Clin Cancer Res; 2011 Aug; 17(16):5257-67. PubMed ID: 21712447
[TBL] [Abstract][Full Text] [Related]
2. The -271 G>A polymorphism of kinase insert domain-containing receptor gene regulates its transcription level in patients with non-small cell lung cancer.
An SJ; Chen ZH; Lin QX; Su J; Chen HJ; Lin JY; Wu YL
BMC Cancer; 2009 May; 9():144. PubMed ID: 19435508
[TBL] [Abstract][Full Text] [Related]
3. Quantitative real-time reverse transcription PCR study of the expression of vascular endothelial growth factor (VEGF) splice variants and VEGF receptors (VEGFR-1 and VEGFR-2) in non small cell lung cancer.
Zygalaki E; Tsaroucha EG; Kaklamanis L; Lianidou ES
Clin Chem; 2007 Aug; 53(8):1433-9. PubMed ID: 17599955
[TBL] [Abstract][Full Text] [Related]
4. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
5. Increased VEGFR-2 gene copy is associated with chemoresistance and shorter survival in patients with non-small-cell lung carcinoma who receive adjuvant chemotherapy.
Yang F; Tang X; Riquelme E; Behrens C; Nilsson MB; Giri U; Varella-Garcia M; Byers LA; Lin HY; Wang J; Raso MG; Girard L; Coombes K; Lee JJ; Herbst RS; Minna JD; Heymach JV; Wistuba II
Cancer Res; 2011 Aug; 71(16):5512-21. PubMed ID: 21724587
[TBL] [Abstract][Full Text] [Related]
6. Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancer.
Yuan A; Yu CJ; Chen WJ; Lin FY; Kuo SH; Luh KT; Yang PC
Int J Cancer; 2000 Nov; 89(6):475-83. PubMed ID: 11102890
[TBL] [Abstract][Full Text] [Related]
7. Elevated SP-1 transcription factor expression and activity drives basal and hypoxia-induced vascular endothelial growth factor (VEGF) expression in non-small cell lung cancer.
Deacon K; Onion D; Kumari R; Watson SA; Knox AJ
J Biol Chem; 2012 Nov; 287(47):39967-81. PubMed ID: 22992725
[TBL] [Abstract][Full Text] [Related]
8. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer.
Koukourakis MI; Giatromanolaki A; Thorpe PE; Brekken RA; Sivridis E; Kakolyris S; Georgoulias V; Gatter KC; Harris AL
Cancer Res; 2000 Jun; 60(11):3088-95. PubMed ID: 10850461
[TBL] [Abstract][Full Text] [Related]
10. Influence of vascular endothelial growth factor single nucleotide polymorphisms on non-small cell lung cancer tumor angiogenesis.
Maeda A; Nakata M; Yasuda K; Yukawa T; Saisho S; Okita R; Hirami Y; Shimizu K
Oncol Rep; 2013 Jan; 29(1):39-44. PubMed ID: 23064377
[TBL] [Abstract][Full Text] [Related]
11. Identification of a Novel Pathogenic Germline KDR Variant in Melanoma.
Silva IP; Salhi A; Giles KM; Vogelsang M; Han SW; Ismaili N; Lui KP; Robinson EM; Wilson MA; Shapiro RL; Pavlick A; Zhong J; Kirchhoff T; Osman I
Clin Cancer Res; 2016 May; 22(10):2377-85. PubMed ID: 26631613
[TBL] [Abstract][Full Text] [Related]
12. Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density.
Fontanini G; Boldrini L; Calcinai A; Chinè S; Lucchi M; Mussi A; Angeletti CA; Basolo F; Bevilacqua G
Clin Cancer Res; 1999 Jan; 5(1):155-61. PubMed ID: 9918214
[TBL] [Abstract][Full Text] [Related]
13. IL-20 is epigenetically regulated in NSCLC and down regulates the expression of VEGF.
Baird AM; Gray SG; O'Byrne KJ
Eur J Cancer; 2011 Aug; 47(12):1908-18. PubMed ID: 21565488
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer.
Chen JJ; Yao PL; Yuan A; Hong TM; Shun CT; Kuo ML; Lee YC; Yang PC
Clin Cancer Res; 2003 Feb; 9(2):729-37. PubMed ID: 12576442
[TBL] [Abstract][Full Text] [Related]
15. Apelin expression in human non-small cell lung cancer: role in angiogenesis and prognosis.
Berta J; Kenessey I; Dobos J; Tovari J; Klepetko W; Jan Ankersmit H; Hegedus B; Renyi-Vamos F; Varga J; Lorincz Z; Paku S; Ostoros G; Rozsas A; Timar J; Dome B
J Thorac Oncol; 2010 Aug; 5(8):1120-9. PubMed ID: 20581707
[TBL] [Abstract][Full Text] [Related]
16. JAK2/STAT3 signaling pathway activation mediates tumor angiogenesis by upregulation of VEGF and bFGF in non-small-cell lung cancer.
Zhao M; Gao FH; Wang JY; Liu F; Yuan HH; Zhang WY; Jiang B
Lung Cancer; 2011 Sep; 73(3):366-74. PubMed ID: 21333372
[TBL] [Abstract][Full Text] [Related]
17. PRL-3 facilitates angiogenesis and metastasis by increasing ERK phosphorylation and up-regulating the levels and activities of Rho-A/C in lung cancer.
Ming J; Liu N; Gu Y; Qiu X; Wang EH
Pathology; 2009 Feb; 41(2):118-26. PubMed ID: 19152186
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer.
Seto T; Higashiyama M; Funai H; Imamura F; Uematsu K; Seki N; Eguchi K; Yamanaka T; Ichinose Y
Lung Cancer; 2006 Jul; 53(1):91-6. PubMed ID: 16697074
[TBL] [Abstract][Full Text] [Related]
19. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-8 in non-small cell lung carcinoma: relation with angiogenic pattern and p53 alterations.
Boldrini L; Gisfredi S; Ursino S; Lucchi M; Mussi A; Basolo F; Pingitore R; Fontanini G
Lung Cancer; 2005 Dec; 50(3):309-17. PubMed ID: 16125276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
